Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
3
75%
Ph phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

enrolling_by_invitation125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
enrolling_by_invitationnot_applicable

Magnetic Stimulation as a Treatment for Stress Urinary Incontinence

NCT05952258
completednot_applicable

Transpelvic Magnetic Stimulation to Improve Urogenital Function

NCT04488068
completednot_applicable

Efficacy of Magnetic Stimulation for Stress Urinary Incontinence

NCT01924728
completedphase_1

Transcranial Magnetic Stimulation in Children With Stroke

NCT01637129

Clinical Trials (4)

Showing 4 of 4 trials
NCT05952258Not Applicable

Magnetic Stimulation as a Treatment for Stress Urinary Incontinence

Enrolling By Invitation
NCT04488068Not Applicable

Transpelvic Magnetic Stimulation to Improve Urogenital Function

Completed
NCT01924728Not Applicable

Efficacy of Magnetic Stimulation for Stress Urinary Incontinence

Completed
NCT01637129Phase 1

Transcranial Magnetic Stimulation in Children With Stroke

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4